Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
1978 - Bryan J McEntire Joins Ceramatec
1999 - Robocasting: Sandia develops new way to fabricate ceramics.
2002 - Amedica files for it's first medical device patent involving silicon Nitride
"The narrative of this story is very compelling" Compelling in the sense that Zimmer can come in and play looky loo all it wants. They contract through Ceramtec. they don't even manufacture ceramics. This must be puzzling you.
Hot off the press: it's happening edition.
https://media.giphy.com/media/rl0FOxdz7CcxO/giphy.gif
https://patents.justia.com/search?q=Ashok+C.+Khandkar
Assignee: Ceramatec, Inc.
PROJECT PROFILE: Ceramatec, Inc. | Department of Energy
"other than most projects are government funded "
"it was a company with a changing focus, from strictly R&D to more commercial, unfortunately the company was not able to turn around in time to survive another 40. Our Parent company provided all the necessary support to facilitate our closure."
"Manager just laugh at you if you get fired. Really psychotic bosses here."
www.ceramatec.com click the link.
14143 Denver West Pkwy Ste 400
Lakewood CO 80401
United States
https://us.kompass.com/c/ceramatec-inc/us352436/
"Commercial Physical and Biological Research"
Design Engineer, ITPM
Level 3
April 2003 – 2010 7 years
Denver, Colorado
https://www.crunchbase.com/person/daniel-chon#section-overview
Anyone got any questions for the CC? I`m good. No questions here. The tweeting issue has been resolved. Only solid question that could garnish an answer. https://patents.justia.com/patent/9353010 do they see any conflicts of intellectual property related to this patent? Is that a good question? should I ask it?
They have a patent for coating PEEK? I thought they where looking at doping it to impart the antibacterial properties? Dump out the Ti in your Osseus Aries robocaster. Pour in a bucket of Si Ni. Print it in Si ni. Please do not look at spine. Nothing to see here. May I direct your attention to these hips sitting on my desk for the last 4 years.
K2M was projected to surpass Stryker in sales somewhere. They where both looking toward titanium 3d printing. If these scout ship relationships do exist, then Osseus is a Zimmer 3d printing Ti hovering over Dallas. https://www.osseus.com/aries-lumbar-ibfd/
"The proprietary lattice" Not sure if small enough but there was a research study into ceramics flexing not breaking with a similar construction.
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K172788
Not sure what the Monet system is out of CTL. Predicative was the Mattisse. CTL doesnt appear to be doing anything with 3d printing. As far as CTL competing against OSSEUS. this is great news for CTL. I would switch out the Ti peek in Mattisse for Si Ni doped Peek at least if not switch Ti to Si Ni. Unfortunately Osseus looks to be the better Suit for amedica, pure tech.Doing everything CTL does, More and prettier. No clue on sales ability, where it matters. You have to pay to play with these docs. Prob. Not so much VA.
Amedica And K2M Ink Distribution Deal In Europe. Acquired by Stryker. Picking through CTL`s indeed data, if there is a link there it's Stryker. Lot's of people gained the experience in Spine at Stryker and list it as their interest on Indeed. To my research Chon appears to be a bit of an enigma. Hook a Stryker flagship? use SiNi as bait. Contract is Hook? then surprise its Zimmer? are these just cousin relationships standard in the south? Stryker is the highest bidder or a nothing burger?
Boston where you suggesting high frequency millennial traders get burned here? Not their topic. Security through Obscurity. It takes a nerds nerd to push through all the data here. If anything they buy right into the bear logic or got burned long ago and learned to stay away. Perhaps they are attracted like flies to the Daily losers gainers list for a 3 day scalp attempt. Perhaps even before the 80 day you could sell Fail to deliver, write an IOU convert and buy up the IOU`s you need on open market in the .30`s probably the same shares you sold earlier.
https://www.tctmagazine.com/3d-printing-news/osseus-fusion-systems-3d-printed-titanium-implants-fda/
operated out of Dallas. track it back and it's a guy that came out of Zimmer years back in round rock with a co. in between that purchased a bunch of Zimmer Chrome trash operating in North Austin. Also found a 3d printing Co. with Operations in Dallas. Pretty sure this "Robocasting" came out of Sandia with a guy out of Sandia on the inside of AMDA. Dallas is pretty nuts. Saw some "triangular" UFO's flying around that turned out to be black ops stealth revealed years later and Some legit UFOS getting chased around by police helicopters at night decades ago that have never been revealed. My dad tried to explain about the skunk works relationships going on in this area but I forget.
Doctors are stupid.
https://www.washingtonpost.com/national/health-science/the-bacteria-fighting-super-element-making-a-return-to-hospitals-copper/2015/09/20/19251704-5beb-11e5-8e9e-dce8a2a2a679_story.html?noredirect=on&utm_term=.7ee4049efe29
Known since the ancient Egypt. Still no wide scale adoption. Notice big words being thrown around like CDC and Defense Dept. Copper relatively easily plates to stainless steel surfaces. Silicon nitride is very difficult to machine after sintering. I know were talking flexible rubber doping here.
Hiring for 3rd shift leads me to believe you're ramping for production. With China tariff and supply chain issues with the FDA in Indiana Coorstek is in an interesting position with their cerasurf. A 5 year multi million dollar plan to expand medical ceramic initiatives. If I where Coorstek AMDA would be on my radar. Publicly even their R&D engineer job listing is to compare the Alumina, Zirconia and Silicon Carbide. Makes no mention that silicon nitride is on the radar. I guess we can mark this one case closed.
No links to Texas. Ortho development is using biolox delta. Zimmer Closed Biomet in Austin. Coorstek Is alpha orbiting both CTI and Amedica in Texas and Utah. Lots of alpha orbiting in Utah. Not alot in Texas much less both. Coincidence? Possibly.
Not confusing the two. JMDM signed an agreement for manufacture in china, Doesnt indicate they are looking at NGK for manufacture with that agreement in place. Not to say NGK or Kyocera are completely out of the running. Kyocera would be wasting $ trying to line up Azul this late in the game. Coorstek getting hold of this and continuing a strategic relationship with CTI sets it up quite nicely to distribute to whoever wants a piece. Or give it to no one conglomerate CTI and compete directly with Zimmer, J&J, stryker etc. Knowing the ins and outs of Silicon Nitride this is probably the best bet. Coorstek has plenty of finances available to sit around until the competition is exhausted.
Someone mentioned hauling equipment to Dallas area from Utah. Might be prudent to mention Coorstek runs a medical device unit in Logan Utah up the road from Amedica and is HQ`ed in the DFW area. Thought I saw some links to CTI dental abilities and Coorstek in DFW.
You got me.potentially reduced inflammation too. Still doctors are stupid.
are you sure selling to CTI is something Wego does not like?
Hopefully you saw my posts on the positive and negatives. I`m torn. If spine constitutes 30% of the potential market without dental then giving away half leaves 85% potential. I dont think thats how it actually works in the financials because of the huge mark up over production costs. Spine is SiNi weakest sector for benefits because of no mechanical wear potential for fusion of the spine. It's only bringing antibacterial properties and osteoconductivity. Something a surgeon won't notice or care because they`re stupid.
Not sure whats going on. The plan was crush amedica not merge? This deal would bring Spine to market so sonny cant be in on that game. Hide the spine from 15 million recent public offering in defense of the jewels? Amedica secretly R&D's for the benefit of humanity with pure altruism and sees profitability as a distraction? some necessity to escape the wego deal?
https://fintel.io/ss/us/amda
If there is a bot that takes control of the bid(which i think there is) It's a low value bot and could be defeated for $300 worth of ask interest at times I've looked at it, to destroy it's ask dominance. I think these things are just facts of life and nothing will be done about them beyond out financing them with bid interest. In the current market the only way to increase bid interest appears to be quarterly beats. Even there they will short and distort and swing trade off the strong support. Hence why growth doesn't occur in a straight line.
Seems like a moot point here. Stock price doesn't fix AMDA's financial woes. A problem directly related to their inability to finance a strong sales team. It could only reduce the amount of preferred shares they would have to print to secure financial life lines that shouldn't be needed with a successful company. Usually the banks hunt loans and financing offers when the loanee doesn`t need a loan. If you really need a loan you probably wont get one.
Flip side of the coin is if a deal isnt signed AMDA continues to hemorrhage sales, loan interest and Reverse splits into bankruptcy possibly before hip, knee and dental are developed. 2.5 mill gets rid of sonny and his 10% interest and puts a huge dent in the Hercules loan. Chon would take financial responsibility for marketing. Probably not cheap to be able to compete here, Amedica cant do it. perhaps any financial hit Amedica takes gives Chon more $ to buy doctors chick fil a and Chon has the government contract connection. How much is it worth to take Sonny off the helm here and bring in the 50 man team of Chon`s heavy hitters? Already known Sonny is overstretched.Possibly leading quickly to some profitability through manufacture to alleviate financial woes and bring in capital with 0 interest to invest in the other 60% of implant market and dental? Maybe worth it to take the hit for the team here to Waifu Chon up.. as long as its not sonny`s secret modus operandi into the future. Not much to lose at this point if this is the real deal business as usual.
looks like compensation from CTL will work like this:
2.5 Million to sonny bal's loan
6 million promissory note to amedica
Not even going to equate the 1.5 sales revenues payout because thats a bonus, not part of a sale agreement.
So that's 8.5 million
https://www.last10k.com/sec-filings/0001269026/0001493152-18-012933.html
according to the latest sec filing they currently have 1,718,00 in finished goods and value their trademarks at 400,000. i`ll round down to 2.1 million. that's 6.4 million after deducting these from the agreement price
Ive counted 58 patents and 24 that appear to relate directly to spine product design. Amedica has 6 silicon nitride implants listed and 3 pedicle screw devices listed(Beyond these 3 I wont go into any product IP R&D US spine is transferring over)
https://www.mddionline.com/how-much-does-510k-device-cost-about-24-million
According to this the average price to bring a product to development is 24 million. We'll give amedica the benefit of the doubt and cut that in a quarter. 6 million invested per device. Amedica keeps the manufacturing IP so half of that is 3 million for 6 products. That's 18 million value for just the silicon nitride.The pedicle screws are purchased from a 3rd party so it's a full IPR&D valuation at 6 million X 3 products on those. So an additional 18 million equals 36 million.
patent applications typically cost between $5,000 and $9,000 plus legal fees. So 24 patents at $5,000 filing fee is $120,000
that's a total valuation of $36,120,000. IMO that is giving the company away. This deal is for 8.5 million. that is 27.5 million short of what I, a complete retard would sell for.
I'm not voting for this. But I dont think it will matter much.
I hope so. I was ok with the deal until I realized they are getting all the patents. That's 30 US spine patents. Do we share holders vote on this? Patents for less than 10 mill just feels hostile to Amedica. Like I said the way I read it they can call off the deal indefinitely and AMEDICA takes a 300k penalty. Zero or Hero here for me.
The possibility the shares might being converted at floor? or the possibility they are being dumped on retail? I agree on dumping on retail. Doesnt make sense unless they sell at .48 and buy back lower.
"CTL Medical Corporation has entered into a definitive agreement with Amedica Corporation (NASDAQ: AMDA) to purchase its commercial spine business, which includes its complete portfolio of spine-related patents and 510ks, as well as any technological advancements directly related to the spine that result from it."
Looks pretty official that CTL is gaining the IP R&D with Amedica tweeting to confirm this is true. Not sure how you can translate this into something good for Shareholders with the price tag of $10 million for US spine and all Silicon nitride spine IP R&D and any R&D that occurs into the future involving spine and any inventory they have laying around. I take back what I said before. Amedica should not tweet.
here is reporting 13.6M market cap on a 4M float
http://shortsqueeze.com/shortinterest/stock/AMDA.htm
This is reporting restricted shares in its market cap data.
Here reports a 4.46M market cap on a 11.8M float.
https://finance.yahoo.com/quote/AMDA/key-statistics?p=AMDA
I think this is more accurate on how many shares where converted and dumped into float. What triggered this?
So you want and expect a big dog to bottom scavenge this? A turn around story would make this palatable with investors. That turn around story is in the making IMO. I might be wrong but I`m detecting a resistance in the force with the idea of team sonny chon. Definitely no immediate gratification involved in a turn around story. I`m reading in between the lines of divestment of financial concern and full focus bringing the final pieces of the puzzle to market. right now this is a foster child. Your big dogs are ugly and will just beat it.
We already know the strategic relationship with Kyocera to meet any demand they cant ramp for. Team Sonny Chon is just as likely.
I dont think so. Bid ask wasnt coming to an agreement. highest bid .46 lowest ask .50
This was my only question ever forwarded to IR. Why are they not using US spines products to maintain profitability and using the proceeds to develop Silicon Nitride? No response from IR. I might have worded it different aka "Where's JavelinMIS? why is it not featured on your website and why does this Zimmer facet gun look so similar if you own the patent" Same thing for the Amedica patent that looks so similar to Biolox delta.
But what is CTL buying? exclusive rights to middle man spines sales division? a division of Amedica reduced to 0 in cost cutting procedure? From the way I read it AMDA has the ability to shut down the deal at any time including tomorrow, hand CTL back 300k and just keep a few mill for funsies. The only thing preventing that is Amedica's personal integrity. If I where WEGO i'd be on phones to both Amedica and CTL Amedica right now.
Amedica isn't just Silicon Nitride. US spine brought over a long list of spinal products that Amedica doesn't appear to market. If they are dropping off marketing and sales to CTL, Along with the name Amedica they for some reason don't need anymore, and reviving US spine product lines This should be good for sales, So I consent. Just wish Amedica was purchasing CTL's sales force not the other way around and keeping the WEGO market penetration. Maybe the usual suspects CAN penetrate the chinese market swinging around their big stick.Whatever they paid for US spine it appears to be undisclosed from a cursory glance.
Well....At least they're tweeting again. Did they just slip out of the Wego exclusivity contract? Anyone saying nobody is interested, that was a team of everybody trying to get hold of her and the Chinese state winning exclusivity.
Where is the Fintel data on who owns preferred shares? What percentage of the Company does this constitute if something where to trigger full conversion? Maybe it's Zimmer? You just said they haven't been successful in market penetration ham handing like I`ve demonstrated. If it's not Zimmer or one of the usual suspects then maybe A BO needs Amedica more than Amedica needs a BO. Do shareholder vote on BO approval? If, true it's a good lesson on kicking dogs and kicking dogs bigger than you.
WinnTi Medical was founded by a group of former senior executives from leading orthopedic companies in China, such as Kanghui, Johnson & Johnson, Medtronic, Stryker and Zimmer
So..they bought themselves. They're going to need to form a single pack if they plan on ___ China's ball court. (omitted for mistranslation)
Mr. Jean-Luc Butel and Mr. Li Bing Yung, two nominees designated by Medtronic,
Butel is still listed as "Non-Executive Director by Shandong Weigao Group Medical Polymer Co. Ltd." can't find dates so these sites might just not have updated his resignation. Did Medtronic divest itself of all the weigao stock? Hard to tell with a chinese company to determine who`s invested and a Us co. that I cant find records of who they are invested in. and a shadow affiliate.